accountor efficacy impact (Adds comment from Bayer spokeswoman) WASHINGTON, Sept 15 (Reuters) - U.S. health regulators warned Bayer AG (BAYG.DE) over the testing and quality of pharmaceutical ingredients made at its Bergkamen, Germany, facility, according to a...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 2-U.S. FDA warns Bayer over German plant
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account